
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Mayo Clinic leadership made the decision to discontinue the sales and marketing efforts of Mayo Clinic Trial Services.
Mayo Clinical Trial Services Changes
On November 5, Mayo Clinic leadership made the decision to discontinue the sales and marketing efforts of Mayo Clinic Trial Services. Effective immediately, Mayo Clinical Trial Services will no longer accept new clients or studies and will devote its activities to completing studies already started. This decision will allow Mayo to focus its efforts on its successful and growing clinical reference laboratory business, Mayo Medical Laboratories, which provides high-quality, specialized, esoteric laboratory testing services to clients throughout the world.






